Japan’s Juntendo University Hospital has entered into a research agreement with SyntheticMR to use SyMRI in its clinical research projects.

SyMRI was developed to deliver multiple and adjustable contrast images, as well as quantitative data from three to six minutes.

The hospital will use SyMRI to determine contrast weighting of MRI for patients with multiple sclerosis (MS) or brain tumor metastases.

The deal with the hospital includes a license of SyMRI Research Edition for research use, which is optimized for clinical research within neuro imaging and includes exportable SyMaps, quantitative T1, T2 and PD maps.

SyMRI enables to generate multiple contrast images from a single scan and adjust the parameter settings after the patient has left, making it possible to graduate images and recreate additional contrasts that were missed.

It uses a different approach to measure tissue properties and synthesize images compared against conventional MRI.

Juntendo University Hospital professor Aoki said: "We particularly appreciate the power of changing the contrast after the scan, which we anticipate will be useful in finding the most suitable contrast settings for each patient.

"We will initially use SyMRI in research projects related to MS and brain tumor metastases, with the aim of later taking it into clinical practice at the hospital."